These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15492810)

  • 1. Detection of S100B, S100A6 and galectin-3 ligands in meningiomas as markers of aggressiveness.
    Hancq S; Salmon I; Brotchi J; Gabius HJ; Heizmann CW; Kiss R; Decaestecker C
    Int J Oncol; 2004 Nov; 25(5):1233-40. PubMed ID: 15492810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100A5: a marker of recurrence in WHO grade I meningiomas.
    Hancq S; Salmon I; Brotchi J; De Witte O; Gabius HJ; Heizmann CW; Kiss R; Decaestecker C
    Neuropathol Appl Neurobiol; 2004 Apr; 30(2):178-87. PubMed ID: 15043715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
    Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
    APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
    Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44 expression in human meningiomas: an immunohistochemical analysis.
    Lewy-Trenda I; Omulecka A; Janczukowicz J; Papierz W
    Pol J Pathol; 2004; 55(1):33-7. PubMed ID: 15195704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of HER2 expression in meningiomas: an immunohistochemical and fluorescence in situ hybridization study.
    Loussouarn D; Brunon J; Avet-Loiseau H; Campone M; Mosnier JF
    Hum Pathol; 2006 Apr; 37(4):415-21. PubMed ID: 16564915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic and proliferative potentials in meningiomas.
    Debiec-Rychter M; Biernat W; Limon J; Kordek R; Izycka E; Borowska-Lehman J; Imieliński B; Liberski PP
    Pol J Pathol; 1999; 50(4):243-8. PubMed ID: 10721264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
    Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
    Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathological and cytogenetic findings in benign, atypical and anaplastic human meningiomas: a study of 60 tumors.
    Cerdá-Nicolás M; López-Ginés C; Pérez-Bacete M; Barcia-Salorio JL; Llombart-Bosch A
    Clin Neuropathol; 2000; 19(6):259-67. PubMed ID: 11128617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of extracellular matrix-related genes in rare variants of meningioma.
    Kwon MJ; Sung CO; Kang SY; Do IG; Suh YL
    Hum Pathol; 2013 Feb; 44(2):260-8. PubMed ID: 22995327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent and atypical meningiomas--a multiparametric study using Ki67 labelling index, AgNOR and DNA Feulgen staining.
    Ferraraccio F; Accardo M; Giangaspero F; Cuccurullo L
    Clin Neuropathol; 2003; 22(4):187-92. PubMed ID: 12908755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between histological grade and MIB-1 and p53 immunoreactivity in meningiomas.
    Ozen O; Demirhan B; Altinörs N
    Clin Neuropathol; 2005; 24(5):219-24. PubMed ID: 16167545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of Ki-67/MIB-1 proliferation index in meningiomas.
    Torp SH; Lindboe CF; Grønberg BH; Lydersen S; Sundstrøm S
    Clin Neuropathol; 2005; 24(4):170-4. PubMed ID: 16033133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of alkaline phosphatase activity predicts meningioma recurrence.
    Bouvier C; Liprandi A; Colin C; Giorgi R; Quilichini B; Metellus P; Figarella-Branger D
    Am J Clin Pathol; 2005 Aug; 124(2):252-8. PubMed ID: 16040297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benign and atypical meningioma metabolic signatures by high-resolution magic-angle spinning molecular profiling.
    Monleón D; Morales JM; Gonzalez-Darder J; Talamantes F; Cortés O; Gil-Benso R; López-Ginés C; Cerdá-Nicolás M; Celda B
    J Proteome Res; 2008 Jul; 7(7):2882-8. PubMed ID: 18507434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monosomy 1p and alkaline phosphatase in meningiomas. Citopathological, histochemical and genetical study in 10 tumors].
    Cerdá-Nicolás M; López-Ginés C; Pérez-Bacete M; Talamantes F; Roldán P
    Med Clin (Barc); 2002 May; 118(17):656-8. PubMed ID: 12028903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic validity of the Ki-67 labeling index using the MIB-1 monoclonal antibody in the grading of meningiomas.
    Devaprasath A; Chacko G
    Neurol India; 2003 Sep; 51(3):336-40. PubMed ID: 14652433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caveolin-1 in meningiomas: expression and clinico-pathological correlations.
    Barresi V; Cerasoli S; Paioli G; Vitarelli E; Giuffrè G; Guiducci G; Tuccari G; Barresi G
    Acta Neuropathol; 2006 Nov; 112(5):617-26. PubMed ID: 16850311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic aggressiveness in benign meningiomas with chromosomal instabilities.
    Monleón D; Morales JM; Gonzalez-Segura A; Gonzalez-Darder JM; Gil-Benso R; Cerdá-Nicolás M; López-Ginés C
    Cancer Res; 2010 Nov; 70(21):8426-34. PubMed ID: 20861191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of integrin-alpha 3 mRNA in meningiomas and its biological significance].
    Chen J; Xu XP
    Ai Zheng; 2002 May; 21(5):526-9. PubMed ID: 12452046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.